1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Levodopa–entacapone–carbidopa intestinal gel : Data from the Swedish national registry for Parkinson's disease
Öthman, Mezin ; Bergquist, Filip ; Odin, Per LU
; Scharfenort, Monica
LU
; Johansson, Anders
; Markaki, Ioanna
; Svenningsson, Per
; Dizdar, Nil
and Nyholm, Dag
LU
(2025)
In European Journal of Neurology
32(1).
- Contribution to journal › Article
- 2024
-
Mark
Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus
Georgiopoulos, Charalampos LU
; Papadimitriou, Stergios
; Nyholm, Dag
LU
; Kilander, Lena
; Löwenmark, Malin
; Fällmar, David
and Virhammar, Johan
(2024)
In Journal of Neuroimaging
34(5).
p.612-618
- Contribution to journal › Article
-
Mark
Motor Efficacy of Subcutaneous DIZ102, Intravenous DIZ101 or Intestinal Levodopa/Carbidopa Infusion
Bergquist, Filip ; Ehrnebo, Mats ; Nyholm, Dag ; Johansson, Anders ; Lundin, Fredrik ; Odin, Per LU
; Svenningsson, Per
; Dizdar, Nil
and Eriksson, Elias
(2024)
In Movement Disorders Clinical Practice
11(9).
p.1095-1102
- Contribution to journal › Article
- 2023
-
Mark
The Impact of COVID-19 on Parkinson's Disease : A Case-Controlled Registry and Questionnaire Study on Clinical Markers and Patients' Perceptions
Cedergren Weber, Gustav LU ; Timpka, Jonathan LU ; Bergquist, Filip ; Bäckström, David ; Dizdar, Nil ; Gunnarsson, Karin ; Nyholm, Dag LU ; Svenningsson, Per and Odin, Per LU
(2023)
In Acta Neurologica Scandinavica
2023.
- Contribution to journal › Article
- 2022
-
Mark
Midbrain area and the hummingbird sign from brain MRI in progressive supranuclear palsy and idiopathic normal pressure hydrocephalus
Virhammar, Johan ; Blohmé, Harald ; Nyholm, Dag LU ; Georgiopoulos, Charalampos LU
and Fällmar, David
(2022)
In Journal of Neuroimaging
32(1).
p.90-96
- Contribution to journal › Article
-
Mark
Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
Bergquist, Filip ; Ehrnebo, Mats ; Nyholm, Dag ; Johansson, Anders ; Lundin, Fredrik ; Odin, Per LU
; Svenningsson, Per
; Hansson, Fredrik
; Bring, Leif
and Eriksson, Elias
, et al.
(2022)
In Neurology
99(10).
p.965-976
- Contribution to journal › Article
- 2021
-
Mark
Close relationships in Parkinson´s disease patients with device-aided therapy
Scharfenort, Monica LU ; Timpka, Jonathan LU ; Sahlström, Thomas ; Henriksen, Tove ; Nyholm, Dag LU and Odin, Per LU
(2021)
In Brain and Behavior
11(6).
- Contribution to journal › Article
- 2020
-
Mark
Parkinsons sjukdom – heterogen och komplex i sitt kliniska uttryck - Individuella kombinationer av symtom som ändrar sig över tid kräver behandlingsjusteringar och anpassningar
Bergquist, Filip LU ; Johansson, Anders ; Dizdar, Nil ; Widner, Håkan LU ; Nyholm, Dag LU ; Odin, Per LU
and Svenningsson, Per
(2020)
In Läkartidningen
117.
- Contribution to journal › Article
-
Mark
Everyday Occupations and Other Factors in Relation to Mental Well-Being among Persons with Advanced Parkinson’s Disease
Hultqvist, Jenny LU ; Sahlström, Thomas ; Timpka, Jonathan LU ; Henriksen, Tove ; Nyholm, Dag ; Odin, Per LU
and Eklund, Mona
LU
(2020)
In Occupational Therapy in Health Care
34(1).
p.1-18
- Contribution to journal › Article
-
Mark
A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia
Svenningsson, Per ; Odin, Per LU
; Dizdar, Nil
; Johansson, Anders
; Grigoriou, Sotirios
LU
; Tsitsi, Panagiota
; Wictorin, Klas
LU
; Bergquist, Filip
; Nyholm, Dag
LU
and Rinne, Juha
, et al.
(2020)
In Movement Disorders
35(6).
p.1046-1054
- Contribution to journal › Article